Skip to main content
. 2024 Jun 11;14:1419256. doi: 10.3389/fonc.2024.1419256

Figure 1.

Figure 1

PRISMA 2020 flow diagram for new systematic reviews which included searches of databases, registers, and other sources. EGFR, epidermal growth factor receptor; ICI, immune checkpoint inhibitor, interstitial lung disease; ILD, interstitial lung disease; NSCLC, non-small lung cancer; TKI, tyrosine kinase inhibitor.